Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Anderson, Karen Sue	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-03	Wendy Wang, Ph.D., M.Sc.
Arnold, Corey Wells	University Of California Los Angeles United States	Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification	5R01CA279666-02	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy	University Of Alabama At Birmingham United States	Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer	5R01CA276683-03
Backman, Vadim	Northwestern University At Chicago United States	Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification	1R01CA289294-01A1	Claire Zhu, Ph.D.
Badu-Tawiah, Abraham	Ohio State University United States	Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening	5R21CA270727-02	Claire Zhu, Ph.D.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02	Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin	Univ Of North Carolina Chapel Hill United States	Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer	5R37CA226969-07	Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al	Saint Joseph Mercy Health System United States	Michigan Cancer Research Consortium NCORP	3UG1CA189971-11S1	Vanessa A. White, M.P.H.
Balaj, Leonora	Massachusetts General Hospital United States	Standardized Molecular Analyses of Glioma EVs	5R01CA237500-05	Matthew Young, Ph.D.
Balskus, Emily Patricia	Harvard University United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297577-01S1	Asad Umar, D.V.M., Ph.D.
Balu, Mihaela	University Of California-Irvine United States	Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma	4R01CA259019-04	Guillermo Marquez, Ph.D.
Banerjee, Imon	Mayo Clinic Arizona United States	Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer	5R01CA289249-02	Nicholas Hodges, Ph.D.
Bao, Ting	Dana-Farber Cancer Inst United States	Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial	5R37CA248563-05	Asad Umar, D.V.M., Ph.D.
Bao, Ting	Dana-Farber Cancer Inst United States	Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial	5R01CA251470-06	Goli Samimi, Ph.D., M.P.H.
Barber, Glen N.	Ohio State University United States	Development of A HTLV-1 Vaccine	7R01CA252049-05	Marjorie Perloff, M.D.